Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$10.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Mar 12 | APRE | Aprea Therapeutics, Inc. | AGRANT◆ | 40,380 | — | — | — | Open the original filing on SEC.gov |
| Mar 12 | APRE | Aprea Therapeutics, Inc. | AGRANT | 10,095 | — | — | +30.2% | Open the original filing on SEC.gov |
| Jan 30 | APRE | Aprea Therapeutics, Inc. | PDBUY◆ | 5,700 | — | — | — | Open the original filing on SEC.gov |
| Jan 30 | APRE | Aprea Therapeutics, Inc. | PBUY | 5,700 | $0.89 | $5.1K | +20.5% | Open the original filing on SEC.gov |
| Dec 10, 2025 | APRE | Aprea Therapeutics, Inc. | PDBUY◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 10, 2025 | APRE | Aprea Therapeutics, Inc. | PBUY | 5,000 | $1.17 | $5.8K | +22.0% | Open the original filing on SEC.gov |